New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
06:32 EDTALXNAlexion announces EC grants orphan drug designation for Soliris
Alexion announced that the European Commission has granted an orphan drug designation to Soliris, a first-in-class terminal complement inhibitor, for the prevention of delayed graft function after solid organ transplantation. DGF is an early and serious complication of organ transplantation that is characterized by the failure of a transplanted organ to function normally immediately following transplantation. In patients undergoing kidney transplantation, patients who develop DGF require dialysis in order to survive.
News For ALXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
07:47 EDTALXNAlexion risk/reward profile favorable, says Barclays
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use